Physician profile
Jacob B Manuel
NPI 1063628964
$65,150.05
in general payments reported to CMS, 2019-2025
13 companies · $445 in 2025
The $445 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53K · 2020: $2,400 · 2021: $2,363 · 2022: $4,993 · 2023: $1,659 · 2024: $732 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,874 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,873.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $962.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $50,330.67 | 2019-2025 | Journey II, Real Intelligence, Ri Hip Navigation |
| Orthalign INC | $13,353.92 | 2019-2024 | Orthalign Plus |
| Stryker Corporation | $1,184.82 | 2021-2025 | Mako, Triathlon, Insignia |
| Pacira Pharmaceuticals Incorporated | $95.13 | 2023-2025 | Exparel, Zilretta, Iovera |
| Biocomposites INC | $31.27 | 2024 | |
| Innovation Technologies INC | $25.08 | 2024 | Irrisept |
| Fidia Pharma USA INC. | $23.98 | 2024 | Triluron |
| Si-Bone, INC. | $22.35 | 2023 | |
| Depuy Synthes Sales INC. | $19.98 | 2022 | |
| Kci USA, INC. | $19.79 | 2022 | |
| Heron Therapeutics, INC. | $16.32 | 2025 | Zynrelef |
| Abbott Laboratories | $15.32 | 2025 | Proclaim |
| Pacira Therapeutics, INC. | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Manuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.